Literature DB >> 11711449

Photodynamic therapy: shedding light on restenosis.

R Mansfield1, S Bown, J McEwan.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11711449      PMCID： PMC1729997          DOI： 10.1136/heart.86.6.612

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  49 in total

Review 1.  The biology of restenosis.

Authors:  C Bauters; J M Isner
Journal:  Prog Cardiovasc Dis       Date:  1997 Sep-Oct       Impact factor: 8.194

2.  Local photodynamic therapy with Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia.

Authors:  A Visonà; A Angelini; S Gobbo; A Bonanome; G Thiene; A Pagnan; D Tonello; E Bonandini; G Jori
Journal:  J Photochem Photobiol B       Date:  2000-09       Impact factor: 6.252

3.  Change in chemical composition of lipids accumulated in atheromas of rabbits following photodynamic therapy.

Authors:  J Hayashi; T Saito; K Aizawa
Journal:  Lasers Surg Med       Date:  1997       Impact factor: 4.025

4.  Porphyrin and haem biosynthesis and its control.

Authors:  C Rimington
Journal:  Acta Med Scand Suppl       Date:  1966

5.  Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects.

Authors:  G M LaMuraglia; N R ChandraSekar; T J Flotte; W M Abbott; N Michaud; T Hasan
Journal:  J Vasc Surg       Date:  1994-02       Impact factor: 4.268

6.  Different effects of photodynamic therapy and gamma-irradiation on vascular smooth muscle cells and matrix : implications for inhibiting restenosis.

Authors:  J Heckenkamp; D Leszczynski; J Schiereck; J Kung; G M LaMuraglia
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

7.  Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).

Authors:  S G Rockson; P Kramer; M Razavi; A Szuba; S Filardo; P Fitzgerald; J P Cooke; S Yousuf; A R DeVault; M F Renschler; D C Adelman
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

8.  Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid.

Authors:  I Nyamekye; S Anglin; J McEwan; A MacRobert; S Bown; C Bishop
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

9.  Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis.

Authors:  G M LaMuraglia; M L Klyachkin; F Adili; W M Abbott
Journal:  J Vasc Surg       Date:  1995-06       Impact factor: 4.268

10.  The effect of photodynamic therapy on the mechanical integrity of normal rabbit carotid arteries.

Authors:  W E Grant; G Buonaccorsi; P M Speight; A J MacRobert; C Hopper; S G Bown
Journal:  Laryngoscope       Date:  1995-08       Impact factor: 3.325
View more
  4 in total

1.  Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model.

Authors:  R Waksman; I M Leitch; J Roessler; H Yazdi; R Seabron; F Tio; R W Scott; R I Grove; S Rychnovsky; B Robinson; R Pakala; E Cheneau
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

2.  Photodynamic therapy of balloon-injured rat carotid arteries using indocyanine green.

Authors:  Jih-Shyong Lin; Chia-Jung Wang; Wen-Tyng Li
Journal:  Lasers Med Sci       Date:  2018-03-28       Impact factor: 3.161

3.  Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT.

Authors:  Magdalena Wawrzyńska; Maciej Duda; Iwona Hołowacz; Aleksandra Kaczorowska; Agnieszka Ulatowska-Jarża; Igor Buzalewicz; Wojciech Kałas; Edyta Wysokińska; Dariusz Biały; Halina Podbielska; Marta Kopaczyńska
Journal:  Materials (Basel)       Date:  2019-12-09       Impact factor: 3.623

4.  In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells.

Authors:  Magdalena Wawrzyńska; Wojciech Kałas; Dariusz Biały; Ewa Zioło; Jacek Arkowski; Walentyna Mazurek; Leon Strzadała
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-02       Impact factor: 4.291
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.